canaloplasty: Definition, Uses, and Clinical Overview

canaloplasty Introduction (What it is)

canaloplasty is an eye surgery designed to lower intraocular pressure (IOP) in certain types of glaucoma.
It works by improving the eye’s natural fluid drainage pathway rather than creating a new drainage hole.
It is most commonly used for open-angle glaucoma and is sometimes combined with cataract surgery.
It is considered a “bleb-less” approach because it typically does not aim to form a filtering bleb under the eyelid.

Why canaloplasty used (Purpose / benefits)

The main goal of canaloplasty is to reduce elevated IOP, which is a major risk factor for optic nerve damage in glaucoma. In glaucoma, pressure can build up when the eye’s internal fluid (aqueous humor) does not drain efficiently. Over time, uncontrolled IOP can contribute to progressive vision loss.

canaloplasty is designed to address this drainage problem by restoring or enhancing outflow through the eye’s conventional pathway—primarily the trabecular meshwork and Schlemm’s canal. Instead of diverting fluid to a new external reservoir, canaloplasty aims to improve the function of the existing drainage channel.

Potential benefits often discussed in clinical settings include:

• Lowering IOP to reduce glaucoma progression risk (degree of IOP reduction varies by clinician and case)
• Reducing dependence on glaucoma eye drops for some patients (varies by clinician and case)
• Avoiding a bleb in many cases, which can change the long-term care needs compared with bleb-forming surgeries
• Being compatible with cataract surgery in select patients when a combined approach is planned

Because glaucoma severity, anatomy, and treatment goals differ widely, the role of canaloplasty is individualized and may be considered among several surgical options.

Indications (When ophthalmologists or optometrists use it)

canaloplasty may be considered in scenarios such as:

• Primary open-angle glaucoma where IOP is not adequately controlled with medications and/or laser, or where reducing medication burden is a goal
• Pseudoexfoliation glaucoma (in some cases) when the angle anatomy is suitable
• Pigmentary glaucoma (in some cases) with an open drainage angle
• Patients in whom a bleb-forming procedure is less desirable due to lifestyle, ocular surface issues, or follow-up considerations (varies by clinician and case)
• Mild to moderate glaucoma, particularly when aiming to use the conventional outflow pathway (severity suitability varies by clinician and case)
• Cases planned for combination with cataract surgery, depending on anatomy and target IOP

Optometrists typically do not perform canaloplasty but may identify glaucoma progression risk, monitor IOP and optic nerve status, and co-manage postoperative care in collaboration with an ophthalmologist where permitted and appropriate.

Contraindications / when it’s NOT ideal

canaloplasty is not ideal for every glaucoma type or eye anatomy. Situations where it may be less suitable or where another approach may be preferred can include:

• Angle-closure glaucoma or eyes with significant peripheral anterior synechiae (scarring/adhesions closing the drainage angle), where access to the conventional outflow pathway is limited
• Neovascular glaucoma, uveitic glaucoma, or other secondary glaucomas with significant inflammation or abnormal vessel growth that can disrupt normal drainage structures
• Advanced glaucoma requiring very low target IOP, where other procedures may be chosen depending on risk–benefit considerations (varies by clinician and case)
• Eyes with significant scarring of the drainage system that limits the ability to catheterize or dilate Schlemm’s canal (varies by clinician and case)
• Prior surgeries or anatomical variations that make the procedure technically difficult or less likely to meet pressure goals (varies by clinician and case)
• Inability to participate in postoperative follow-up, since pressure monitoring and assessment of healing are important for any glaucoma procedure

Suitability is determined through a full glaucoma evaluation, including angle assessment and a discussion of target IOP and risk tolerance.

How it works (Mechanism / physiology)

Mechanism of action (high level)

canaloplasty aims to improve aqueous humor outflow through the eye’s natural drainage route. The procedure typically involves:

• Viscodilation: expanding Schlemm’s canal using a viscoelastic material to widen the channel and reduce resistance.
• Tensioning (in some techniques): placing a suture within Schlemm’s canal to apply gentle inward tension to the trabecular meshwork, which may help keep the pathway more open.

The overall intention is to reduce resistance to outflow at the level of the trabecular meshwork and Schlemm’s canal, lowering IOP.

Relevant anatomy (simple explanations)

• Aqueous humor is the clear fluid produced inside the eye that nourishes tissues and maintains eye shape.
• Trabecular meshwork is a sieve-like tissue at the drainage angle where most aqueous humor exits.
• Schlemm’s canal is a circular channel that collects aqueous humor after it passes through the trabecular meshwork.
• Collector channels connect Schlemm’s canal to veins, ultimately returning fluid to the bloodstream.

In open-angle glaucoma, the drainage angle looks open on exam, but microscopic resistance within these structures can still impair outflow.

Onset, duration, and reversibility

canaloplasty is a surgical procedure, so it is not “reversible” in the way a medication can be stopped. The IOP-lowering effect is typically assessed over postoperative visits as healing stabilizes. How long the effect lasts depends on glaucoma type, anatomy, healing response, and whether the drainage system remains functional; this varies by clinician and case.

canaloplasty Procedure overview (How it’s applied)

The exact steps differ by surgical technique (and by surgeon), but a general workflow often includes:

1. Evaluation and planning
   – Comprehensive glaucoma assessment (IOP, optic nerve evaluation, visual field testing, imaging as indicated).
   – Examination of the drainage angle (gonioscopy) to confirm suitability for a conventional outflow approach.
   – Review of current medications, prior eye surgeries, and cataract status.

2. Preparation
   – Procedure is typically performed in an operating room or surgical center.
   – Local anesthesia is commonly used; the choice of anesthesia varies by clinician and case.
   – The eye is cleaned and draped in a sterile manner.

3. Intervention (high-level concept)
   – The surgeon gains access to Schlemm’s canal (approach depends on the variation used).
   – A microcatheter or similar device may be threaded through Schlemm’s canal.
   – The canal may be dilated with viscoelastic as the device is withdrawn.
   – In some techniques, a suture is left in place to provide tension within the canal.

4. Immediate checks
   – The surgeon checks wound integrity and immediate IOP-related signs.
   – Postoperative drops are commonly prescribed to manage inflammation and reduce infection risk (specific regimens vary).

5. Follow-up
   – Follow-up visits monitor IOP, vision, inflammation, and healing.
   – Medication plans may be adjusted based on pressure response and optic nerve needs (varies by clinician and case).

This overview is intentionally general; the full technique and instrumentation are surgeon-specific and tailored to the patient’s eye.

Types / variations

canaloplasty has multiple variations based on how Schlemm’s canal is accessed and whether it is combined with other procedures.

• Ab externo canaloplasty (external approach)
  Access to Schlemm’s canal is obtained from the outside of the eye through scleral layers. This is often what people mean by “traditional” canaloplasty and may include placement of a tensioning suture.

• Ab interno canaloplasty (internal approach)
  Schlemm’s canal is accessed from inside the eye through the anterior chamber angle using a gonioscopic view. In clinical conversation, ab interno canaloplasty is sometimes discussed within the broader category of minimally invasive glaucoma surgery (MIGS), though terminology can vary.

• canaloplasty combined with cataract surgery
  Some patients undergo a combined plan when both cataract and glaucoma management are being addressed. The combined approach and expected outcomes depend on baseline IOP, glaucoma severity, and the specific technique used.

• canaloplasty with additional angle procedures
  In some surgical strategies, canal-based dilation may be combined with other angle-based steps intended to improve outflow. The exact combination depends on surgeon preference, device availability, and individual anatomy.

Because devices and techniques evolve, the exact instrumentation and naming conventions can vary by material and manufacturer.

Pros and cons

Pros:

• Targets the eye’s natural drainage system (conventional outflow pathway)
• Often described as bleb-less compared with trabeculectomy-style filtering surgeries
• Can be an option for patients seeking IOP reduction with a different risk profile than bleb-forming procedures (varies by clinician and case)
• May be combined with cataract surgery in selected cases
• Postoperative management may differ from bleb-dependent procedures, which can be a practical consideration for some patients
• Preserves future options in many treatment plans, since glaucoma care is often stepwise (varies by clinician and case)

Cons:

• Not appropriate for all glaucoma types, especially those with angle closure or severe secondary causes
• Degree of IOP lowering may be insufficient for eyes needing very low target pressures (varies by clinician and case)
• Surgical success depends on anatomy and healing responses that cannot be fully predicted
• Complications are possible, such as bleeding in the front of the eye (hyphema), transient pressure changes, or inflammation (risk varies by clinician and case)
• Requires follow-up to monitor IOP response and optic nerve stability
• Availability may be limited by surgeon training, equipment, or regional practice patterns

Aftercare & longevity

Aftercare following canaloplasty generally focuses on monitoring healing and confirming that IOP is controlled over time. Typical postoperative themes include:

• Follow-up schedule: Early and repeated checks are used to track IOP, inflammation, and visual recovery. The schedule varies by clinician and case.
• Medication adjustments: Some patients remain on glaucoma drops, some reduce them, and others restart medications later if IOP rises; this is individualized.
• Healing and inflammation control: Anti-inflammatory drops are commonly used after intraocular surgery, and the duration depends on clinical findings.
• Ocular surface health: Dry eye and ocular surface irritation can affect comfort and vision quality, especially in people who have used long-term glaucoma drops.
• Comorbidities: Diabetes, uveitis history, prior surgeries, and other factors can influence healing and longer-term pressure stability.
• Longevity of effect: Long-term performance depends on how well the drainage system continues to function and how the eye heals; there is no single fixed duration that applies to everyone.

In glaucoma, “longevity” is also measured by whether optic nerve structure and visual fields remain stable over time, not only by IOP.

Alternatives / comparisons

canaloplasty is one option within a broader glaucoma treatment spectrum. Alternatives are selected based on glaucoma type, target IOP, disease stage, and patient-specific factors.

• Observation / monitoring
  In early or low-risk cases, clinicians may monitor IOP, optic nerve appearance, imaging, and visual fields. Monitoring does not lower IOP by itself but may be appropriate when risk is low or treatment tradeoffs outweigh benefits.

• Medications (eye drops and sometimes oral agents)
  Drops can reduce aqueous production or increase outflow. They are non-surgical and adjustable over time, but effectiveness can vary, side effects can occur, and adherence is a practical challenge for some patients.

• Laser trabeculoplasty (e.g., SLT)
  Laser treatment can improve outflow through the trabecular meshwork in open-angle glaucoma. It is performed in clinic, is repeatable in some cases, and may reduce drop burden, though results vary and may diminish over time.

• Other MIGS procedures
  Angle-based stents, trabeculotomy/goniotomy-type procedures, and other canal-based interventions also aim to improve conventional outflow. They differ in mechanism, invasiveness, and typical IOP outcomes, and choice depends on anatomy and surgical goals.

• Trabeculectomy and tube shunts (filtering surgeries)
  These procedures create alternate pathways for fluid to leave the eye. They are often used when lower target IOP is needed but can involve bleb-related care and different complication profiles. The tradeoffs compared with canaloplasty are individualized and depend on disease severity and risk tolerance.

Balanced decision-making typically considers the target IOP needed to protect the optic nerve, the likelihood of achieving it with each approach, and the acceptable risk and follow-up burden.

canaloplasty Common questions (FAQ)

Q: Is canaloplasty a glaucoma cure?
No. Glaucoma is generally considered a chronic condition that requires ongoing monitoring. canaloplasty is designed to lower IOP, which can help reduce risk of progression, but it does not restore lost optic nerve tissue. Long-term follow-up remains important.

Q: Does canaloplasty hurt?
During surgery, anesthesia is used to reduce pain, and many patients report pressure or mild discomfort rather than sharp pain. After surgery, irritation or soreness can occur as the eye heals. Pain experiences vary by clinician and case, and new or severe pain is typically treated as a reason for prompt clinical evaluation.

Q: How long is recovery after canaloplasty?
Early healing often occurs over days to weeks, but visual stability and pressure stabilization can take longer. Some people notice fluctuating vision during the healing period due to inflammation or temporary changes in the eye. Recovery timelines vary based on technique, whether cataract surgery is also performed, and individual healing response.

Q: How long do the results last?
There is no single fixed duration. Some eyes maintain improved IOP control for years, while others may need additional medications, laser, or further surgery over time. Longevity depends on glaucoma type, anatomy, and how the drainage system heals and functions.

Q: Will I still need glaucoma drops after canaloplasty?
Possibly. Some patients can reduce the number of drops, while others may continue the same regimen or restart drops later if IOP rises. The goal is pressure control tailored to optic nerve risk, and medication plans commonly evolve with follow-up findings.

Q: Is canaloplasty considered “safe”?
All eye surgeries carry risks, and safety is best understood as a balance of benefits and potential complications for a given person. canaloplasty is often discussed as having a different risk profile than bleb-forming filtering surgeries, but it still involves intraocular steps and postoperative monitoring. Individual risk varies by clinician and case.

Q: What does canaloplasty cost?
Costs vary widely by country, facility, surgeon, insurance coverage, and whether it is combined with cataract surgery. Device choice and billing codes can also affect total cost. For accurate expectations, patients usually need a facility-specific estimate.

Q: Can I drive or use screens after canaloplasty?
Vision can be blurry initially, and some people are light sensitive during early healing. Whether driving is appropriate depends on visual clarity and local legal requirements, and many clinicians advise waiting until vision is stable enough to drive safely. Screen use is often possible, but comfort may be limited by dryness or blur early on.

Q: What complications can happen after canaloplasty?
Possible issues include transient inflammation, temporary IOP spikes or low IOP, bleeding in the front of the eye (hyphema), and visual fluctuations. Infection is a rare but serious risk for any intraocular procedure. The likelihood and management of complications vary by clinician and case.

Q: How does canaloplasty compare with trabeculectomy?
Trabeculectomy creates a new outflow pathway and is often used when very low target IOP is needed, but it can require bleb-related monitoring and has its own set of risks. canaloplasty aims to enhance natural drainage and is often considered in eyes where a canal-based approach is appropriate. The best comparison depends on the IOP target, glaucoma severity, and patient-specific anatomy and priorities.